JUPITER NEUROSCIENCES, INC. 10-Q Filing

From the Filing

0001493152-25-023603.txt : 20251114 0001493152-25-023603.hdr.sgml : 20251114 20251114165545 ACCESSION NUMBER: 0001493152-25-023603 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 59 CONFORMED PERIOD OF REPORT: 20250930 FILED AS OF DATE: 20251114 DATE AS OF CHANGE: 20251114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JUPITER NEUROSCIENCES, INC. CENTRAL INDEX KEY: 0001679628 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 474828381 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-41265 FILM NUMBER: 251487803 BUSINESS ADDRESS: STREET 1: 1001 NORTH US HWY 1 STREET 2: SUITE 504 CITY: JUPITER STATE: FL ZIP: 33477 BUSINESS PHONE: (561) 406-6154 MAIL ADDRESS: STREET 1: 1001 NORTH US HWY 1 STREET 2: SUITE 504 CITY: JUPITER STATE: FL ZIP: 33477 FORMER COMPANY: FORMER CONFORMED NAME: Jupiter Orphan Therapeutics, Inc. DATE OF NAME CHANGE: 20160713 10-Q 1 form10-q.htm 10-Q false Q3 --12-31 0001679628 0001679628 2025-01-01 2025-09-30 0001679628 2025-11-14 0001679628 2025-09-30 0001679628 2024-12-31 0001679628 us-gaap:RelatedPartyMember 2025-09-30 0001679628 us-gaap:RelatedPartyMember 2024-12-31 0001679628 us-gaap:SeriesAPreferredStockMember 2025-09-30 0001679628 us-gaap:SeriesAPreferredStockMember 2024-12-31 0001679628 2025-07-01 2025-09-30 0001679628 2024-07-01 2024-09-30 0001679628 2024-01-01 2024-09-30 0001679628 us-gaap:CommonStockMember 2025-06-30 0001679628 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001679628 JUNS:ReceivablesForSaleOfStockMember 2025-06-30 0001679628 us-gaap:RetainedEarningsMember 2025-06-30 0001679628 2025-06-30 0001679628 us-gaap:CommonStockMember 2024-12-31 0001679628 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001679628 us-gaap:RetainedEarningsMember 2024-12-31 0001679628 us-gaap:CommonStockMember 2024-06-30 0001679628 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001679628 JUNS:ReceivablesForSaleOfStockMember 2024-06-30 0001679628 us-gaap:RetainedEarningsMember 2024-06-30 0001679628 2024-06-30 0001679628 us-gaap:CommonStockMember 2023-12-31 0001679628 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001679628 JUNS:ReceivablesForSaleOfStockMember 2023-12-31 0001679628 us-gaap:RetainedEarningsMember 2023-12-31 0001679628 2023-12-31 0001679628 us-gaap:CommonStockMember 2025-07-01 2025-09-30 0001679628 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0001679628 JUNS:ReceivablesForSaleOfStockMember 2025-07-01 2025-09-30 0001679628 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0001679628 us-gaap:CommonStockMember 2025-01-01 2025-09-30 0001679628 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-09-30 0001679628 us-gaap:RetainedEarningsMember 2025-01-01 2025-09-30 0001679628 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001679628 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001679628 JUNS:ReceivablesForSaleOfStockMember 2024-07-01 2024-09-30 0001679628 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001679628 us-gaap:CommonStockMember 2024-01-01 2024-09-30 0001679628 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-09-30 0001679628 JUNS:ReceivablesForSaleOfStockMember 2024-01-01 2024-09-30 0001679628 us-gaap:RetainedEarningsMember 2024-01-01 2024-09-30 0001679628 us-gaap:CommonStockMember 2025-09-30 0001679628 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0001679628 JUNS:ReceivablesForSaleOfStockMember 2025-09-30 0001679628 us-gaap:RetainedEarningsMember 2025-09-30 0001679628 us-gaap:CommonStockMember 2024-09-30 0001679628 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001679628 JUNS:ReceivablesForSaleOfStockMember 2024-09-30 0001679628 us-gaap:RetainedEarningsMember 2024-09-30 0001679628 2024-09-30 0001679628 2024-04-01 2024-06-30 0001679628 us-gaap:CommonStockMember 2024-12-01 2024-12-31 0001679628 us-gaap:CommonStockMember 2025-03-21 0001679628 2025-09-17 0001679628 us-gaap:CommonStockMember 2025-07-09